Macquarie Group’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44K | Hold |
6,000
| – | – | ﹤0.01% | 1591 |
|
|
2025
Q1 | $52K | Hold |
6,000
| – | – | ﹤0.01% | 1567 |
|
|
2024
Q4 | $215K | Hold |
6,000
| – | – | ﹤0.01% | 1510 |
|
|
2024
Q3 | $284K | Hold |
6,000
| – | – | ﹤0.01% | 1529 |
|
|
2024
Q2 | $302K | Hold |
6,000
| – | – | ﹤0.01% | 1525 |
|
|
2024
Q1 | $672K | Hold |
6,000
| – | – | ﹤0.01% | 1419 |
|
|
2023
Q4 | $348K | Hold |
6,000
| – | – | ﹤0.01% | 1502 |
|
|
2023
Q3 | $191K | Hold |
6,000
| – | – | ﹤0.01% | 1531 |
|
|
2023
Q2 | $494K | Hold |
6,000
| – | – | ﹤0.01% | 1455 |
|
|
2023
Q1 | $617K | Hold |
6,000
| – | – | ﹤0.01% | 1437 |
|
|
2022
Q4 | $879K | Sell |
6,000
-152
| -2% | -$22.3K | ﹤0.01% | 1444 |
|
|
2022
Q3 | $1.04M | Sell |
6,152
-25
| -0.4% | -$4.24K | ﹤0.01% | 1409 |
|
|
2022
Q2 | $713K | Hold |
6,177
| – | – | ﹤0.01% | 1547 |
|
|
2022
Q1 | $617 | Hold |
6,177
| – | – | ﹤0.01% | 1620 |
|
|
2021
Q4 | $960K | Sell |
6,177
-94
| -1% | -$14.6K | ﹤0.01% | 1564 |
|
|
2021
Q3 | $1.48M | Buy |
6,271
+211
| +3% | +$49.8K | ﹤0.01% | 1473 |
|
|
2021
Q2 | $2.06M | Hold |
6,060
| – | – | ﹤0.01% | 1411 |
|
|
2021
Q1 | $2.45M | Sell |
6,060
-18
| -0.3% | -$7.28K | ﹤0.01% | 1132 |
|
|
2020
Q4 | $4.04M | Hold |
6,078
| – | – | 0.01% | 922 |
|
|
2020
Q3 | $2.83M | Hold |
6,078
| – | – | ﹤0.01% | 949 |
|
|
2020
Q2 | $3.56M | Buy |
+6,078
| New | +$3.56M | 0.01% | 869 |
|